What Happened?
Los Angeles, CA-based Puma Biotechnology Appointed Gordon Esplin as Chief Accounting Officer
About the Company
We focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
About the Person
Gordon Esplin is Chief Accounting Officer at Puma Biotechnology. Previously, Gordon held various senior HR leadership roles in the industry.
Info Source
News
Short Profile